A carregar...
Histone deacetylase inhibitors: emerging mechanisms of resistance
The histone deacetylase inhibitors (HDIs) have shown promise in the treatment of a number of hematologic malignancies, leading to the approval of vorinostat and romidepsin for the treatment of cutaneous T-cell lymphoma and romidepsin for the treatment of peripheral T-cell lymphoma by the U. S. Food...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230675/ https://ncbi.nlm.nih.gov/pubmed/21899343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp200329f |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|